What does CUSIP 23256X100 represent in this 13F holders report?

CUSIP 23256X100 is the security identifier for CYBN - CYBIN INC. - Common Shares, no par value used to aggregate holder disclosures.

How many institutions held CYBN - CYBIN INC. - Common Shares, no par value in Q4 2022?

61 institutional investors reported CYBN - CYBIN INC. - Common Shares, no par value for Q4 2022. Use the holders table for investor-level position and value details.

CYBIN INC. - Common Shares, no par value (CYBN)

CUSIP: 23256X100

Q4 2022 13F Holders as of 31 Dec 2022

Security type / class: Equity / Common Shares, no par value
Total 13F shares: 11,316,981
Total 13F value: $3,414,299
Share change: -5,474,779
SEC-reported price per share: $0.30
Number of holders: 61
Value change: -$1,890,451
Number of buys: 29
Number of sells: 19
Shares outstanding: 49,047,786

Security key

23256X100

Report period

Q4 2022

Institutions

Top holders

CYBN full security history Ownership snapshot Full 13F holder table CYBIN INC. SEC filings CYBIN INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of CYBN - CYBIN INC. - Common Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ORBIMED ADVISORS LLC

Disclosed value leader

ORBIMED ADVISORS LLC

Comparable rows

15/15

Latest evidence

30 Sep 2022

13F Lead comparable stake: 21% Showing 1-6 of 15 holder rows.

Quick read

ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 21%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.

Comparable ownership Top 5

ORBIMED ADVISORS LLC 21%

MORGAN STANLEY 5.4%

AdvisorShares Investments LLC 2.9%

BlackRock Finance, Inc. 1.5%

CANTOR FITZGERALD, L. P. 0.61%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ORBIMED ADVISORS LLC	13F Company 13F	21%	$5,082,000 10,453,600 shares	—	30 Sep 2022
MORGAN STANLEY	13F Company 13F	5.4%	$1,274,000 2,631,710 shares	—	30 Sep 2022
AdvisorShares Investments LLC	13F Company 13F	2.9%	$697,000 1,439,433 shares	—	30 Sep 2022
BlackRock Finance, Inc.	13F Company 13F	1.5%	$362,000 748,212 shares	—	30 Sep 2022
CANTOR FITZGERALD, L. P.	13F Individual 13F	0.61%	$145,000 300,000 shares	—	30 Sep 2022
ROYAL BANK OF CANADA	13F Company 13F	0.22%	$52,000 109,239 shares	—	30 Sep 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

11,316,981

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

Q4 2022 holders

Holder diff

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 value	Q4 2022 value	Value change	Value Chg %